Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mercury compounds

This article was originally published in The Tan Sheet

Executive Summary

FDA informational document, "Mercury Compounds in Drugs and Foods," lists and analyzes mercury compounds intentionally introduced into drug and food products. The agency requested data on such products in December and April ("The Tan Sheet" Dec. 21, 1998, p. 17). FDA received information on 16 OTC products containing mercury compounds as inactive ingredients, including 14 nasal sprays/drops and two ophthalmic products. A total of 41 responses were received; FDA also reviewed information in its Drug Registration and Listing System as well as other sources to identify additional products. The agency received no data on dietary supplements

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090614

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel